Download www.endogenet.org Molecular Genetics Service Profile d3

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Site-specific recombinase technology wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Deoxyribozyme wikipedia , lookup

Point mutation wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Polymorphism (biology) wikipedia , lookup

Gene therapy wikipedia , lookup

RNA-Seq wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

NEDD9 wikipedia , lookup

Microevolution wikipedia , lookup

Helitron (biology) wikipedia , lookup

Designer baby wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Transcript
Responsiveness to
GH treatment
www.endogenet.org
Molecular Genetics Service Profile
d3-GHR (Growth Hormone Receptor Gene Polymorphism)
Introduction
!
The GHR gene is encoding the Growth Hormone Receptor, which is expressed in all human
tissues. The GHR gene has been mapped to chromosome 5p13-p12, spans approximately 300 kb,
and consists of 10 exons, which encode a predicted protein of 638 amino acids.
!
Due to alternative splicing there are 2 isoforms of GHR in humans: a full-length isoform and an
isoform that lacks exon 3 (d3-GHR).
!
Patients with a hetero- or homozygous allele encoding the d3-GHR isoform have increased
responsiveness to exogenous Growth Hormone (GH). Therefore screening the d3polymorphism may be useful in SGA (small for gestational age) or ISS (idiopathic short stature)
children before treatment with GH to predict the patients individual response.
Please photocopy and distribute this sheet as required
Reasons for referral
!
d3-polymorphism screening in patients before treatment with GH to predict individual
responsiveness.
Samples
!
Minimum of 2 ml blood sample in EDTA (or minimum of 50 µg DNA from peripheral lymphocytes)
can be sent to our laboratory by express mail.
Technical
!
DNA amplification using multiplex PCR and agarose gel electrophoresis.
Target turn-round time
!
1 week from the receipt of all required samples and clinical information.
Cost
!
Allelic variant detection (d3-GHR) - € 60. In special cases we will provide this service as part of our
research program. Please contact us directly.
References
!
Dos Santos C et al. “A common polymorphism of the growth hormone receptor is associated with
increased responsiveness to growth hormone.” Nat Genet. 2004 Jul;36(7):720-4. Epub 2004 Jun
20.
!
Pantel J et al., “Species-specific alternative splice mimicry at the growth hormone receptor locus
revealed by the lineage of retroelements during primate evolution.”, J Biol Chem. 2000 Jun 23;
275(25):18664-9.
Contact:
Prof. Dr. Roland Pfäffle, University Hospital for Children and Adolescents, Oststr. 21-25, 04317
Leipzig. Tel.: +49-341-9726123. Fax: +49-341-9726349. Email: [email protected]
Johannes FW Weigel and Roland W Pfäffle (2004)